Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2757)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 14, 2023 (publication date) through May 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Brzdęk M, Zarębska-Michaluk D, Invernizzi F, Cilla M, Dobrowolska K, Flisiak R. Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C. World J Gastroenterol 2023; 29(6): 949-966 [PMID: 36844142 DOI: 10.3748/wjg.v29.i6.949] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i6/949.htm |
| Number | Citing Articles |
| 1 |
Jiyoung Lee, J.-H. James Ou. HCV-induced autophagy and innate immunity. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1305157
|
| 2 |
Muhammad Shahab, Abbas Khan, Salman Ali Khan, Guojun Zheng. Unraveling the mechanisms of Sofosbuvir resistance in HCV NS3/4A protease: Structural and molecular simulation-based insights. International Journal of Biological Macromolecules 2024; 267: 131629 doi: 10.1016/j.ijbiomac.2024.131629
|
| 3 |
Krystyna Dobrowolska, Michał Brzdęk, Piotr Rzymski, Robert Flisiak, Małgorzata Pawłowska, Jakub Janczura, Kinga Brzdęk, Dorota Zarębska-Michaluk. Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals. Expert Opinion on Pharmacotherapy 2024; doi: 10.1080/14656566.2024.2358139
|
| 4 |
Malik Sallam, Roaa Khalil. Contemporary Insights into Hepatitis C Virus: A Comprehensive Review. Microorganisms 2024; 12(6): 1035 doi: 10.3390/microorganisms12061035
|
| 5 |
Krystyna Dobrowolska, Małgorzata Pawłowska, Dorota Zarębska‐Michaluk, Piotr Rzymski, Ewa Janczewska, Magdalena Tudrujek‐Zdunek, Hanna Berak, Włodzimierz Mazur, Jakub Klapaczyński, Beata Lorenc, Justyna Janocha‐Litwin, Anna Parfieniuk‐Kowerda, Dorota Dybowska, Anna Piekarska, Rafał Krygier, Beata Dobracka, Jerzy Jaroszewicz, Robert Flisiak. Direct‐acting antivirals in women of reproductive age infected with hepatitis C virus. Journal of Viral Hepatitis 2024; 31(6): 309 doi: 10.1111/jvh.13936
|
| 6 |
Ahmed B. Zaid, Shimaa K. Almady, Samah M. Awad, Mona G. Elabd, Sara A. Saied, AbdulRahman A Saied, Alshimaa M Elmalawany. Sofosbuvir (+) daclatasvir (+) ribavirin in Egyptian patients with hepatitis C virus: Therapeutic outcomes and the prognostic role of natural killer cells. Current Research in Translational Medicine 2024; 72(3): 103443 doi: 10.1016/j.retram.2024.103443
|